Fricke E, Fricke H, Eckert S, et al. Myocardial sympathetic innervation in patients with chroniccoronary artery disease: is reduction in coronary flow reservecorrelated with sympathetic denervation[J]. Eur J Nucl Med Mol Imaging， 2007，34: 206-211.
[2]
Franziums C, Hermann K, Weckesser M, et al. Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I MIBG SPECT/CT[J]. J Nucl Med, 2006, 47: 1 635-1 642.
[3]
Thackeray JT, BeanlandsRS, DaSilva JN. Presence of specific 11C-meta-hydroxyephedrine retention in heart, lung, pancreas, and brown adipose tissue[J]. J Nucl Med, 2007, 48: 1 733-1 740.
[4]
Rosenspire KC, Haka MS, Van Dort ME, et al. Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging[J]. J Nucl Med, 1990, 31: 1 328-1 334.
[5]
Ngren K, Müller L, Halldin C, et al. Improved synthesis of some commonly used PET radioligands by the use of [11C]methyl triflate[J]. Nucl Med Biol, 1995, 22(2): 235-239.
[6]
Van Dort ME, Tluczek L. Synthesis and carbon-11 labeling of the stereoisomers of meta-hydroxyephedrine (HED) and meta-hydroxypseudoephedrine (HPED)[J]. J Labelled Cpd Radiopharm, 2000, 43(6): 603-612.
Law MP, Osman S, Davenport RJ, et al. Biodistribution and metabolism of [Nmethyl-11C] m-hydroxyephedrine in the rat[J]. Nucl Med Biol, 1997, 24(5): 417-424.
